Pioglitazone Tablet
Product Images NDC 60687-905

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Pioglitazone (NDC 60687-905). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

00093 7271 98 Nlmimage10 B543da9e

Pioglitazone 15 mg or 30 mg oral tablets, round and white, with embossed markings 'TEVA' on one side and '7271' on the other side. The tablets are unscored and manufactured or labeled by American Health Packaging.*

FDA Label Image

15 mg Pioglitazone Tablets Carton Label (0439101 0219os Pioglitazone Tab 15mg)

Pioglitazone Tablets USP 15 mg oral tablets, packaged in a bottle containing 100 tablets (10 blister packs of 10). The label includes dosing and storage instructions, manufacturer Teva Pharmaceuticals USA, Inc., and distributor American Health Packaging, Columbus, Ohio. The product is prescription only with a barcode and NDC 60687-391-01.*

FDA Label Image

15 mg Pioglitazone Tablet Blister (15 mg Pioglitazone Tablet Blister)

Pioglitazone Tablet USP 15 mg oral dosage form packaging label from American Health Packaging. The label includes the drug name, strength (15 mg), lot number (123456), expiration date (08/18), barcode, and manufacturer information. The design is repeated multiple times on the sheet for individual tablet packaging.*

FDA Label Image

Chemical Structure (Chemical Structure)

Chemical structure of pioglitazone hydrochloride, showing the molecular arrangement of atoms including carbon, hydrogen, nitrogen, oxygen, sulfur, and chlorine in the compound.*

FDA Label Image

Figure 1: Mean Change From Baseline For Hba1c In A 26 Week Placebo-controlled Dose-ranging Study (observed Values) (Image 01)

Line graph showing mean values over 26 weeks for four treatment groups: placebo, 15 mg, 30 mg, and 45 mg doses. The x-axis represents time in weeks, and the y-axis represents the mean measurement. Each group is represented by distinct markers and colors, tracking response trends over the study duration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.